채혈 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 채취 부위별, 용도별, 방법별, 최종 용도별, 지역별 및 경쟁(2021-2031년)

The Global Blood Collection Market is projected to expand from USD 10.86 Billion in 2025 to USD 16.13 Billion by 2031, reflecting a CAGR of 6.82%. This market encompasses specialized apparatus such as vacuum tubes, needles, and blood bags utilized for diagnostic and transfusion purposes. The primary growth factors include the increasing burden of chronic diseases like cancer, alongside an aging demographic that demands frequent medical care. Furthermore, the rising occurrence of trauma cases and the ongoing development of healthcare infrastructure in emerging nations continue to reinforce the demand for secure collection technologies.

Despite these growth prospects, the sector encounters obstacles such as enduring supply chain instability and a shortage of donors. Data from the Association for the Advancement of Blood and Biotherapies in 2025 indicated that securing type O negative blood for immediate use often necessitated a lead time of 48 hours or more, underscoring severe logistical difficulties. These inefficiencies, coupled with the high costs associated with strict regulatory compliance for donor safety, threaten to restrict market expansion, particularly in resource-constrained environments.

Market Driver

The rising prevalence of lifestyle-related and chronic diseases serves as a major driver for the Global Blood Collection Market. Ailments such as diabetes and cancer require regular blood sampling for diagnosis, treatment tracking, and disease management, thereby maintaining a high consumption rate of collection supplies. For example, the 'Cancer Facts & Figures 2025' report by the American Cancer Society, released in January 2025, projects approximately 2,041,910 new cancer diagnoses in the United States, highlighting the urgent necessity for dependable collection tools in oncology. This heavy disease burden forces healthcare facilities to maintain substantial inventories of essential items, including needles and vacuum tubes, to ensure uninterrupted diagnostic services.

Concurrently, government programs encouraging voluntary blood donation are reshaping the market by fortifying supply chains for transfusion needs. National health bodies are increasingly funding collection infrastructure to guarantee safe blood reserves for emergency trauma and surgical procedures. According to the World Health Organization's 'Blood safety and availability' fact sheet from May 2025, roughly 118.54 million blood donations are collected globally, demonstrating the massive scale of operations requiring collection devices. This volume generates significant revenue for leading manufacturers; for instance, Becton, Dickinson and Company reported that their Life Sciences segment earned $1.3 billion in the first quarter of 2025, a figure driven largely by strong sales volumes of blood collection products.

Market Challenge

A significant obstacle hindering the Global Blood Collection Market is the persistent shortage of blood donors. This issue directly suppresses market expansion by lowering collection volumes, which act as the primary determinant for the consumption of disposable items like blood bags, vacuum tubes, and needles. Since the market relies heavily on volume, any decrease in donor participation results in an immediate reduction in the procurement of these single-use devices. Additionally, chronic shortages introduce unpredictability into procurement cycles, compelling manufacturers to navigate volatile ordering patterns instead of benefiting from the consistent demand growth usually associated with improved healthcare infrastructure and an aging population.

This structural instability is emphasized by recent statistics revealing critical inventory gaps. In February 2025, America's Blood Centers reported that 25% of blood centers in the southern United States were operating with critical supply levels of one day or less. Such severe shortages illustrate that, despite the growing clinical need for blood products, the actual market potential for collection equipment is limited by the failure to secure adequate donor turnout, which directly impedes revenue growth for industry participants.

Market Trends

The rise of Remote and At-Home Blood Collection Models is fundamentally transforming traditional phlebotomy by decentralizing the process of sample acquisition. This shift is supported by the use of microsampling devices that enable patients to independently collect capillary blood, thereby easing the logistical strain on hospitals and enhancing compliance for decentralized clinical trials. Moving toward self-administration represents a scalable operational strategy that manufacturers are actively pursuing to address growing healthcare consumerism, rather than a mere convenience. The rapid adoption of these patient-focused solutions is evident in significant commercial achievements; for example, Tasso, Inc. announced in an October 2025 press release that it had reached a milestone of selling two million blood collection devices, highlighting the strong market penetration of remote sampling technologies.

At the same time, the market is undergoing a notable shift toward Specialized Preservation Tubes designed for Genomics and Liquid Biopsy applications. With advancements in molecular diagnostics, there is a crucial need for collection tubes equipped with proprietary preservatives that stabilize cell-free DNA (cfDNA) and prevent genomic contamination caused by white blood cell lysis during transit. This trend transitions the blood collection sector from basic consumables to high-value medical devices vital for non-invasive prenatal testing and oncology workflows. The demand for these advanced tubes tracks closely with the surging volume of genomic assays in diagnostic labs; for instance, Natera, Inc.'s 'Third Quarter 2025 Financial Results' from November 2025 reported approximately 211,000 oncology tests performed in that quarter alone-a 53.9% year-over-year increase-fueling a concurrent rise in the use of specialized stabilization tubes.

Key Market Players

• NIPRO Medical Corporation
• Abbott Laboratories Inc.
• Becton, Dickinson and Company
• Terumo Corporation
• Qiagen N.V
• Medtronic plc
• FL Medical s.r.l.
• SARSTEDT AG & Co. KG
• Greiner Holding AG
• Haemonetics Corporation

Report Scope

In this report, the Global Blood Collection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Collection Market, By Collection Site

• Venous
• Capillary

Blood Collection Market, By Application

• Diagnostics
• Treatment

Blood Collection Market, By Method

• Manual
• Automated

Blood Collection Market, By End-use

• Hospitals
• Blood Banks
• Others

Blood Collection Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Collection Market.

Available Customizations:

Global Blood Collection Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Collection Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Collection Site (Venous {Needles and Syringes, Blood collection Tubes, Blood Bags, Others}, Capillary {Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices, Others})
  • 5.2.2. By Application (Diagnostics, Treatment)
  • 5.2.3. By Method (Manual, Automated)
  • 5.2.4. By End-use (Hospitals, Blood Banks, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Blood Collection Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Collection Site
  • 6.2.2. By Application
  • 6.2.3. By Method
  • 6.2.4. By End-use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Collection Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Collection Site
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Method
      • 6.3.1.2.4. By End-use
  • 6.3.2. Canada Blood Collection Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Collection Site
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Method
      • 6.3.2.2.4. By End-use
  • 6.3.3. Mexico Blood Collection Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Collection Site
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Method
      • 6.3.3.2.4. By End-use

7. Europe Blood Collection Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Collection Site
  • 7.2.2. By Application
  • 7.2.3. By Method
  • 7.2.4. By End-use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Collection Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Collection Site
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Method
      • 7.3.1.2.4. By End-use
  • 7.3.2. France Blood Collection Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Collection Site
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Method
      • 7.3.2.2.4. By End-use
  • 7.3.3. United Kingdom Blood Collection Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Collection Site
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Method
      • 7.3.3.2.4. By End-use
  • 7.3.4. Italy Blood Collection Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Collection Site
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Method
      • 7.3.4.2.4. By End-use
  • 7.3.5. Spain Blood Collection Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Collection Site
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Method
      • 7.3.5.2.4. By End-use

8. Asia Pacific Blood Collection Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Collection Site
  • 8.2.2. By Application
  • 8.2.3. By Method
  • 8.2.4. By End-use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Collection Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Collection Site
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Method
      • 8.3.1.2.4. By End-use
  • 8.3.2. India Blood Collection Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Collection Site
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Method
      • 8.3.2.2.4. By End-use
  • 8.3.3. Japan Blood Collection Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Collection Site
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Method
      • 8.3.3.2.4. By End-use
  • 8.3.4. South Korea Blood Collection Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Collection Site
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Method
      • 8.3.4.2.4. By End-use
  • 8.3.5. Australia Blood Collection Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Collection Site
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Method
      • 8.3.5.2.4. By End-use

9. Middle East & Africa Blood Collection Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Collection Site
  • 9.2.2. By Application
  • 9.2.3. By Method
  • 9.2.4. By End-use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Collection Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Collection Site
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Method
      • 9.3.1.2.4. By End-use
  • 9.3.2. UAE Blood Collection Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Collection Site
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Method
      • 9.3.2.2.4. By End-use
  • 9.3.3. South Africa Blood Collection Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Collection Site
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Method
      • 9.3.3.2.4. By End-use

10. South America Blood Collection Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Collection Site
  • 10.2.2. By Application
  • 10.2.3. By Method
  • 10.2.4. By End-use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Collection Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Collection Site
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Method
      • 10.3.1.2.4. By End-use
  • 10.3.2. Colombia Blood Collection Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Collection Site
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Method
      • 10.3.2.2.4. By End-use
  • 10.3.3. Argentina Blood Collection Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Collection Site
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Method
      • 10.3.3.2.4. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Collection Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. NIPRO Medical Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Abbott Laboratories Inc.
• 15.3. Becton, Dickinson and Company
• 15.4. Terumo Corporation
• 15.5. Qiagen N.V
• 15.6. Medtronic plc
• 15.7. FL Medical s.r.l.
• 15.8. SARSTEDT AG & Co. KG
• 15.9. Greiner Holding AG
• 15.10. Haemonetics Corporation

16. Strategic Recommendations

17. About Us & Disclaimer